Burosumab
Product Specifications
CAS Number
1610833-03-8
Target
Others
Related Pathways
Others
Purity
0.984
Bioactivity
Burosumab (KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2168583-01 0.1 mL
FITC-Linked Monoclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
Ask
View Details MBS2168583-02 0.2 mL
FITC-Linked Monoclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
Ask
View Details MBS2168583-03 0.5 mL
FITC-Linked Monoclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
Ask
View Details 
MBS2168583-04 1 mL
FITC-Linked Monoclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
Ask
View Details MBS2168583-05 5 mL
FITC-Linked Monoclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
Ask
View Details MBS2168583-06 5x 5 mL
FITC-Linked Monoclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
Ask
View Details